Dialysis Patient's Finger Calcification Resolves After Treatment Change
Doctors in Spain report a rare complication of kidney failure that cleared once phosphorus and parathyroid hormone levels were brought down.
Updated on Nov. 18, 2026 in Diabetes

Doctors in Spain describe a 34-year-old woman on home dialysis who developed a calcified mass on her right middle finger, diagnosed as uremic tumoral calcinosis. The mass reached near-complete remission after her phosphorus and parathyroid hormone levels fell with a revised treatment plan.
Why it matters
The case shows that a rare calcium-phosphate complication of kidney failure can be treated with medication and dialysis changes rather than surgery alone. It adds to the limited literature on managing this condition in people on peritoneal dialysis.
The authors' review of 26 previously reported cases found only two that reached remission with medical therapy alone, and surgical removal of the parathyroid glands carried a recurrence rate of up to 66%. Whether this patient's remission will hold over time has not been reported.
The players
Medical Sciences
Medical Sciences is a peer-reviewed open-access journal that publishes biomedical research across clinical and basic science fields.
The details
The woman's kidney failure was caused by lupus nephritis, and about 20 months after starting peritoneal dialysis she developed a swelling on her right middle finger. An X-ray showed a calcified mass around the finger bone, and her phosphorus and parathyroid hormone levels were markedly elevated, with all four parathyroid glands enlarged on a PET/CT scan. Doctors kept her on the calcium-free binder sevelamer, raised her cinacalcet dose, and switched her to automated peritoneal dialysis, and surgery to remove the parathyroid glands was postponed.
Timeline
About 20 months after starting peritoneal dialysis, the calcified finger mass developed.
January 29, 2025: the case was published in the journal Medical Sciences.
June 2024: phosphorus and parathyroid hormone had fallen and the mass had reached near-complete remission.
Health Landscape
Among peritoneal dialysis patients, uremic tumoral calcinosis has a documented prevalence of about 1.6% in a Japanese study cited by the authors. This Spanish case adds a single, uncommon example to a condition that remains poorly studied.
For people on peritoneal dialysis, calcium-phosphate imbalance can lead to hard calcified masses that may be treated by adjusting binders, calcimimetics and dialysis type rather than surgery alone. Anyone experiencing unexplained swelling or pain near joints while on dialysis should raise it with their care team promptly.
The takeaway
Persistent swelling in a dialysis patient can signal a metabolic problem rather than a local injury, and treating the underlying phosphorus and parathyroid imbalance may be enough to resolve it. Patients should report new lumps or pain to their nephrology team.
Further reading
For related coverage of metabolic and kidney-linked conditions, see the Diabetes section.
Source note: This article includes information reported by Medical Daily.



